BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 16979342)

  • 1. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun C; Zhang X; Huang H; Zhou P
    Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
    Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel class of potent influenza virus inhibitors: polysubstituted acylthiourea and its fused heterocycle derivatives.
    Sun C; Huang H; Feng M; Shi X; Zhang X; Zhou P
    Bioorg Med Chem Lett; 2006 Jan; 16(1):162-6. PubMed ID: 16216505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
    Liu AL; Wang HD; Lee SM; Wang YT; Du GH
    Bioorg Med Chem; 2008 Aug; 16(15):7141-7. PubMed ID: 18640042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
    J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of influenza neuraminidase inhibitors.
    Abdel-Magid AF; Maryanoff CA; Mehrman SJ
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):776-91. PubMed ID: 11899618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.
    Nair PC; Sobhia ME
    Eur J Med Chem; 2008 Feb; 43(2):293-9. PubMed ID: 17513019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
    Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
    Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.
    Liu Y; Zhang L; Gong J; Fang H; Liu A; Du G; Xu W
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):506-13. PubMed ID: 21143042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
    Abu Hammad AM; Taha MO
    J Chem Inf Model; 2009 Apr; 49(4):978-96. PubMed ID: 19341295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and anti-influenza viral activities of 1,3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors.
    Kinger M; Park YD; Park JH; Hur MG; Jeong HJ; Park SJ; Lee WS; Kim SW; Yang SD
    Arch Pharm Res; 2012 Mar; 35(4):633-8. PubMed ID: 22553055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-influenza virus activity of biflavonoids.
    Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
    Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors.
    Lou J; Yang X; Rao Z; Qi W; Li J; Wang H; Li Y; Li J; Wang Z; Hu X; Liu P; Hong X
    Eur J Med Chem; 2014 Aug; 83():466-73. PubMed ID: 24992074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.
    Wen WH; Wang SY; Tsai KC; Cheng YS; Yang AS; Fang JM; Wong CH
    Bioorg Med Chem; 2010 Jun; 18(11):4074-84. PubMed ID: 20452227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
    Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
    Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
    Stanley M; Martin SR; Birge M; Carbain B; Streicher H
    Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition.
    Ryu YB; Curtis-Long MJ; Kim JH; Jeong SH; Yang MS; Lee KW; Lee WS; Park KH
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6046-9. PubMed ID: 18938076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
    Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
    Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.